97. Ulcerative colitis Clinical trials / Disease details


Clinical trials : 2,630 Drugs : 1,459 - (DrugBank : 265) / Drug target genes : 144 - Drug target pathways : 202

  
5 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2007-004867-22-SK
(EUCTR)
25/05/200928/05/2009A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AVONEX® in Subjects with Moderate to Severe Ulcerative Colitis.A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AVONEX® in Subjects with Moderate to Severe Ulcerative Colitis. Moderate to Severe Ulcerative Colitis
MedDRA version: 9.1;Level: LLT;Classification code 10045365;Term: Ulcerative colitis
Trade Name: Avonex
Product Name: Avonex
Biogen Idec LtdNULLNot RecruitingFemale: yes
Male: yes
120Phase 2Czech Republic;Hungary;Slovakia
2EUCTR2007-004867-22-CZ
(EUCTR)
07/10/200826/02/2008A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AVONEX® in Subjects with Moderate to Severe Ulcerative Colitis.A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AVONEX® in Subjects with Moderate to Severe Ulcerative Colitis. Moderate to Severe Ulcerative Colitis
MedDRA version: 9.1;Level: LLT;Classification code 10045365;Term: Ulcerative colitis
Trade Name: Avonex
Product Name: Avonex
Biogen Idec LtdNULLNot RecruitingFemale: yes
Male: yes
120Hungary;Czech Republic
3EUCTR2007-004867-22-HU
(EUCTR)
18/06/200821/02/2008A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AVONEX® in Subjects with Moderate to Severe Ulcerative Colitis.A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AVONEX® in Subjects with Moderate to Severe Ulcerative Colitis. Moderate to Severe Ulcerative Colitis
MedDRA version: 9.1;Level: LLT;Classification code 10045365;Term: Ulcerative colitis
Trade Name: Avonex
Product Name: Avonex
Biogen Idec LtdNULLNot RecruitingFemale: yes
Male: yes
120Hungary;Czech Republic
4NCT00616434
(ClinicalTrials.gov)
May 20085/2/2008A Phase 2 Study of Interferon Beta-1a (Avonex®) in Ulcerative ColitisA Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of Avonex® in Subjects With Moderate to Severe Ulcerative ColitisActive Ulcerative ColitisDrug: BG9418 (Interferon beta-1a);Drug: PlaceboBiogenNULLCompleted18 Years65 YearsAll123Phase 2United States;Canada;Czech Republic;Hungary;Poland;Russian Federation;Slovakia
5NCT00048347
(ClinicalTrials.gov)
October 200229/10/2002Interferon-beta1a (AVONEX) Treatment of Ulcerative ColitisAn Open-Label, Pilot Study of Type I Interferon (AVONEX) Treatment of Ulcerative ColitisUlcerative ColitisDrug: AVONEXNational Institute of Allergy and Infectious Diseases (NIAID)NULLCompleted18 YearsN/AAll18Phase 2United States